TROPHAMINE (amino acids)
TROPHAMINE is indicated for the treatment of Weight Loss; Negative Nitrogen Balance.
Details
- Status
- Prescription
- First Approved
- 1984-07-20
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
TROPHAMINE Approval History
What TROPHAMINE Treats
2 indicationsTROPHAMINE is approved for 2 conditions since its original approval in 1984. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Weight Loss
- Negative Nitrogen Balance
TROPHAMINE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to TROPHAMINE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
4 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT03709264 PROTection | PROTection/47/OSR | Ph 3 | completed | Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery. |
| NCT07001098 AKI | 80133 | Ph 2 | not yet recruiting | Amino Acids for Cardiac Surgery Associated AKI |
| NCT03273712 results posted | 201708778 R01CA167632, 201412770 | Ph 2 | completed | Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) |
| NCT03013387 | 201611818 1R01CA167632-01 | Ph 2 | withdrawn | Dosimetry Guided PRRT With 90Y-DOTATOC |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TROPHAMINE FDA Label Details
Indications & Usage
FDA Label (PDF)TROPHAMINE is indicated for the treatment of Weight Loss; Negative Nitrogen Balance.
Track TROPHAMINE with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.